<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre=" Inflammation induced by" exact="influenza" post="virus impairs innate control of human pneumococcal carriage |"/>
 <result pre="innate control of human pneumococcal carriage | bioRxiv Abstract Secondary" exact="bacterial pneumonia" post="following influenza infection is a significant cause of mortality"/>
 <result pre="control of human pneumococcal carriage | bioRxiv Abstract Secondary bacterial" exact="pneumonia" post="following influenza infection is a significant cause of mortality"/>
 <result pre="human pneumococcal carriage | bioRxiv Abstract Secondary bacterial pneumonia following" exact="influenza" post="infection is a significant cause of mortality worldwide. Upper"/>
 <result pre="unclear in humans. Loss of this control of carriage following" exact="influenza" post="infection is associated with secondary bacterial pneumonia during seasonal"/>
 <result pre="control of carriage following influenza infection is associated with secondary" exact="bacterial pneumonia" post="during seasonal and pandemic outbreaks. We used a human"/>
 <result pre="of carriage following influenza infection is associated with secondary bacterial" exact="pneumonia" post="during seasonal and pandemic outbreaks. We used a human"/>
 <result pre="clearance of pneumococcal carriage. Prior nasal infection with live attenuated" exact="influenza" post="virus induced inflammation, impaired innate function and altered genome-wide"/>
 <result pre="The burden of disease is aggravated by old age, chronic" exact="lung disease," post="immunosupression and viral co-infection. Secondary pneumonia following pandemic and"/>
 <result pre="old age, chronic lung disease, immunosupression and viral co-infection. Secondary" exact="pneumonia" post="following pandemic and seasonal influenza virus infection is a"/>
 <result pre="immunosupression and viral co-infection. Secondary pneumonia following pandemic and seasonal" exact="influenza" post="virus infection is a significant cause of mortality worldwide"/>
 <result pre=". Immune dysregulation caused by respiratory virus infection such as" exact="influenza" post="leads to increased carriage density 8 . Increased carriage"/>
 <result pre="density 8 . Increased carriage density has been associated with" exact="pneumonia" post="incidence and severity, as well as with within-household Spn"/>
 <result pre="rapid nature of the disease. One safe way to simulate" exact="influenza" post="infection in the nose is using Live Attenuated Influenza"/>
 <result pre="is using Live Attenuated Influenza Vaccine (LAIV), consisting of cold-adapted" exact="influenza" post="viruses. LAIV has been shown to affect the subsequent"/>
 <result pre="21 . Moreover, how these mechanisms are altered during human" exact="influenza" post="virus infection remains largely unknown. In recent years, systems"/>
 <result pre="challenge with LAIV and Spn, to emulate nasal effects of" exact="influenza" post="infection on Spn carriage. We identified for the first"/>
 <result pre="acquired pneumococcal carriage, and how they are disrupted following nasal" exact="influenza" post="infection. Results LAIV-induced inflammation leads to increased pneumococcal carriage"/>
 <result pre="for an effect on pneumococcal carriage, we administered tetravalent inactivated" exact="influenza" post="vaccine (TIV) as a control (n=62). LAIV infection led"/>
 <result pre="a) Experimental design of the study. LAIV = live attenuated" exact="influenza" post="vaccine, Spn = &amp;lt;;em&amp;gt;;Streptococcus pneumoniae&amp;lt;;/em&amp;gt;;. Analysed timepoints are indicated"/>
 <result pre="a) Experimental design of the study. LAIV = live attenuated" exact="influenza" post="vaccine, Spn = Streptococcus pneumoniae. Analysed timepoints are indicated"/>
 <result pre="Fig 1d). This suggests that differences in the response to" exact="influenza" post="virus are associated with secondary susceptibility to Spn. To"/>
 <result pre="were also impaired systemically following LAIV as reported during wild-type" exact="influenza" post="infection 32 , we isolated blood neutrophils before, and"/>
 <result pre="a sialyl transferase and cleavage of sialic acids by the" exact="influenza" post="neuraminidase has previously been shown to promote pneumococcal growth"/>
 <result pre="immune responses that control and clear Spn carriage and how" exact="influenza" post="infection can alter this control. By using for the"/>
 <result pre="impaired these immune responses following carriage. LAIV is an attenuated" exact="influenza" post="strain and wild-type influenza viruses might have even more"/>
 <result pre="following carriage. LAIV is an attenuated influenza strain and wild-type" exact="influenza" post="viruses might have even more pronounced effects on the"/>
 <result pre="The association of TIGIT in this impaired neutrophil function following" exact="influenza" post="infection warrants further investigation as TIGIT-blocking therapeutics are currently"/>
 <result pre="further investigation as TIGIT-blocking therapeutics are currently being developed for" exact="cancer" post="and HIV treatment 45 . We identified IP-10 as"/>
 <result pre="had higher bacterial density. In a recent study, children with" exact="pneumonia" post="with viral and bacterial (predominantly pneumococcal) co-infection had increased"/>
 <result pre="levels of IP-10 compared to children with just viral or" exact="bacterial pneumonia," post="which associated with disease severity 46 . Murine data"/>
 <result pre="addition of exogenous IP-10 prior to infection of mice with" exact="influenza" post="or RSV increased pneumonia severity 48 . Our results"/>
 <result pre="prior to infection of mice with influenza or RSV increased" exact="pneumonia" post="severity 48 . Our results support previous findings from"/>
 <result pre="consent, no immunocompromised state or contact with susceptible individuals, no" exact="influenza" post="vaccine or infection in the last two years and"/>
 <result pre="Taubenberger, J. K. &amp;amp;; Fauci, A. S. Predominant role of" exact="bacterial pneumonia" post="as a cause of death in pandemic influenza: implications"/>
 <result pre="J. K. &amp;amp;; Fauci, A. S. Predominant role of bacterial" exact="pneumonia" post="as a cause of death in pandemic influenza: implications"/>
 <result pre="a cause of death in pandemic influenza: implications for pandemic" exact="influenza" post="preparedness. J Infect Dis 198, 962– 970 , doi:"/>
 <result pre="Mina, M. J. &amp;amp;; Klugman, K. P. The role of" exact="influenza" post="in the severity and transmission of respiratory bacterial disease."/>
 <result pre="role of influenza in the severity and transmission of respiratory" exact="bacterial disease." post="Lancet Respir Med 2, 750– 763 , doi: 10.1016/S2213-2600(14)70131-6"/>
 <result pre=", McCullers, J. A. &amp;amp;; Klugman, K. P. Live attenuated" exact="influenza" post="vaccine enhances colonization of Streptococcus pneumoniae and Staphylococcus aureus"/>
 <result pre="Weiser, J. N. Synergistic stimulation of type I interferons during" exact="influenza" post="virus coinfection promotes Streptococcus pneumoniae colonization in mice. J"/>
 <result pre="Inhibition of pulmonary antibacterial defense by interferon-gamma during recovery from" exact="influenza" post="infection. Nat Med 14, 558– 564, doi:nm1765 [pii] 10.1038/nm1765"/>
 <result pre="B. &amp;amp;; Moran, T. M. Type I interferon induction during" exact="influenza" post="virus infection increases susceptibility to secondary Streptococcus pneumoniae infection"/>
 <result pre="D. et al. Systems biology approach predicts immunogenicity of the" exact="yellow fever" post="vaccine in humans. Nat Immunol 10, 116– 125 ,"/>
 <result pre="of gut microbiota is necessary for antibody responses to seasonal" exact="influenza" post="vaccination. Immunity 41, 478– 492 , doi: 10.1016/j.immuni.2014.08.009 ("/>
 <result pre="et al. Systems analysis of protective immune responses to RTS,S" exact="malaria" post="vaccination in humans. Proceedings of the National Academy of"/>
 <result pre="H. I. et al. Systems biology of vaccination for seasonal" exact="influenza" post="in humans. Nat Immunol 12, 786– 795 , doi:"/>
 <result pre="and TLR3 are both required for maximum interferon induction by" exact="influenza" post="virus in human lung alveolar epithelial cells. Virology 482,"/>
 <result pre="Hoffmann, J. et al. Viral and bacterial co-infection in severe" exact="pneumonia" post="triggers innate immune responses and specifically enhances IP-10: a"/>
 <result pre="Pathological observations of lung inflammation after administration of IP-10 in" exact="influenza" post="virus- and respiratory syncytial virus-infected mice. Exp Ther Med"/>
</results>
